| Alma Counseling Center Pllc | |
|
116 W Superior St Suite 6 Alma MI 48801-1650 | |
| (989) 331-4545 | |
| (989) 463-6390 |
| Full Name | Alma Counseling Center Pllc |
|---|---|
| Speciality | Social Worker |
| Location | 116 W Superior St, Alma, Michigan |
| Authorized Official Name and Position | Mary Beth Houpt (CREDENTIALING) |
| Authorized Official Contact | 5176769788 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Alma Counseling Center Pllc Po Box 10 Mason MI 48854-0010 Ph: (517) 676-9788 | Alma Counseling Center Pllc 116 W Superior St Suite 6 Alma MI 48801-1650 Ph: (989) 331-4545 |
| NPI Number | 1467818468 |
|---|---|
| Provider Enumeration Date | 01/06/2016 |
| Last Update Date | 01/06/2016 |
| Medicare PECOS PAC ID | 6709180193 |
|---|---|
| Medicare Enrollment ID | O20160204001750 |
News Archive
BioTime, Inc. and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.
Nearly 60% of Americans are skeptical that Congress and the White House will reach an agreement that will avoid the fiscal cliff, according to a new national public opinion poll commissioned by Research!America.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
April 12th 2015 marks the 60th anniversary of the publication of Jonas Salk's landmark polio vaccine trial results, which confirmed that the first vaccine against polio was safe and effective. A new review, which was published online ahead of print in Future Microbiology, provides a comprehensive overview of current polio vaccines, and highlights new and future research initiatives, such as new vaccine formulations, that could help ensure that polio is eradicated and eradication is maintained.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467818468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6801058855 (Michigan) | Primary |
| Provider Name | Michael Scott Brady |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1366530271 PECOS PAC ID: 6103881271 Enrollment ID: I20070102000271 |
News Archive
BioTime, Inc. and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.
Nearly 60% of Americans are skeptical that Congress and the White House will reach an agreement that will avoid the fiscal cliff, according to a new national public opinion poll commissioned by Research!America.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
April 12th 2015 marks the 60th anniversary of the publication of Jonas Salk's landmark polio vaccine trial results, which confirmed that the first vaccine against polio was safe and effective. A new review, which was published online ahead of print in Future Microbiology, provides a comprehensive overview of current polio vaccines, and highlights new and future research initiatives, such as new vaccine formulations, that could help ensure that polio is eradicated and eradication is maintained.
› Verified 4 days ago
| Provider Name | Daniel Alonzi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831481290 PECOS PAC ID: 3072731165 Enrollment ID: I20140903001046 |
News Archive
BioTime, Inc. and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.
Nearly 60% of Americans are skeptical that Congress and the White House will reach an agreement that will avoid the fiscal cliff, according to a new national public opinion poll commissioned by Research!America.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
April 12th 2015 marks the 60th anniversary of the publication of Jonas Salk's landmark polio vaccine trial results, which confirmed that the first vaccine against polio was safe and effective. A new review, which was published online ahead of print in Future Microbiology, provides a comprehensive overview of current polio vaccines, and highlights new and future research initiatives, such as new vaccine formulations, that could help ensure that polio is eradicated and eradication is maintained.
› Verified 4 days ago
News Archive
BioTime, Inc. and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.
Nearly 60% of Americans are skeptical that Congress and the White House will reach an agreement that will avoid the fiscal cliff, according to a new national public opinion poll commissioned by Research!America.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
April 12th 2015 marks the 60th anniversary of the publication of Jonas Salk's landmark polio vaccine trial results, which confirmed that the first vaccine against polio was safe and effective. A new review, which was published online ahead of print in Future Microbiology, provides a comprehensive overview of current polio vaccines, and highlights new and future research initiatives, such as new vaccine formulations, that could help ensure that polio is eradicated and eradication is maintained.
› Verified 4 days ago
Solutions Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 223 E Superior St, Suite B, Alma, MI 48801 Phone: 989-365-2241 | |
Zenlightenment Wellness Center Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 E Superior St, Alma, MI 48801 Phone: 989-285-1818 | |
Addiction Solutions Counseling Center, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 N State St, Suite 5, Alma, MI 48801 Phone: 989-968-4048 | |
Firefly Learning Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 308 Gratiot Ave, Alma, MI 48801 Phone: 989-284-2154 Fax: 989-331-6550 | |
Mra Psychiatrics, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 733 W Warwick Dr Unit A, Alma, MI 48801 Phone: 989-423-0672 Fax: 989-466-6454 | |
Mymichigan Medical Center Alma Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-463-1101 | |
Mymichigan Medical Center Alma Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 315 E Warwick Dr, Suite F-1, Alma, MI 48801 Phone: 989-463-0957 Fax: 989-968-4032 |